NPY2 receptor agonists
AssigneeBoehringer Ingelheim Internatioal GmbH
InventorsPeter Wilhelm Haebel, Albert Brennauer, Charlotte Stahl Madsen, Soren Ljungberg Pedersen, Stefan Peters
Life of this patent
Estimating the term…
Abstract
The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates to pharmaceutical compositions comprising such PYY analogues, and to the medical use of the analogues.
Claims12
A PYY analogue comprising:
- or a pharmaceutically acceptable salt thereof.
A PYY analogue, wherein the PYY analogue is:
- or a pharmaceutically acceptable salt thereof.
A PYY analogue comprising:
A PYY analogue, wherein the PYY analogue is:
A PYY analogue comprising:
- wherein the PYY analogue is in the form of a pharmaceutically acceptable salt.
A PYY analogue, wherein the PYY analogue is:
- wherein the PYY analogue is in the form of a pharmaceutically acceptable salt.
Dependencies are inferred from the claim text.